Scientific News
Fecal microbial transplant could be a promising treatment for intestinal graft-versus-host disease caused by stem cell transplantation.
A new study published in Nature found that a specific combination of gut microbes can worsen the symptoms of multiple sclerosis in mice.
The gut microbiota can shape our antibodies before we encounter a disease-causing microbe, a new study published in Nature has found.
Researchers have found that giving preterm babies probiotics can help to improve the gut microbiota and displace harmful bacteria.
A new study suggests that 24-hour changes in the gut microbiota could help to predict who’s at risk of developing type 2 diabetes.
A metabolite produced by the gut microbiota increases the risk of colon cancer in mice prone to the disease, a new study has found.
Gut microbiota could make the anti-diabetic drug metformin less effective, researchers from the University of Gothenburg have found.
Researchers have found that skin microbiota plays a key role in wound-healing processes.
Researchers have found that the development of liver cancer can be associated with alterations of the gut microbiota.
A study published in Science Advances suggests that optimizing the gut microbiota can inhibit the development of Alzheimer’s disease.
Researchers have identified the factors that influence the composition of the urinary microbiota in older women.
A new study evaluates the association of multiple breast milk feeding practices with infant gut microbiota composition during a baby’s first year.
A new study, published in Cell Metabolism, identified a microbial signature that is able to diagnose cirrhosis in people.
Researchers have found that alterations in the gut microbiota composition in prediabetic people could contribute to type 2 diabetes.
A study published in Nature could help to determine how intestinal motility is regulated and understand systemic disorders related to the gut-brain axis.
A new study assessed that transplantation of human microbiota into mice durably reshapes the gut microbial community.
To examine the link between autism and gut microbes, researchers led by Anne Konkle at the University of Ottawa analyzed the recent scientific literature.
Researchers have developed molecules that remodel the gut microbiota to a healthier state, reducing cholesterol levels and inhibiting atherosclerosis.
PharmaBiome has developed unique technologies to access the entire range of intestinal bacteria. We met Christophe Lacroix, Founder of Pharmabiome.
Researchers have developed an approach that uses bacterial biofilms to increase the ability of the gut microbiota to survive and reside in the gastrointestinal tract.
